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MISDIAGNOSES OF ENDOGENOUS DEPRESSION
WITH RESEARCH DIAGNOSTIC CRITERIA
SIR,&mdash;Dr Nelson and colleagues, commenting on their ex-
perience with the research diagnostic criteria (R.D.C.)2 for the
diagnosis of major depressive disorder (M.D.D.), primary sub-
type, drew attention to the problem of false-positive diagnoses,
which they ascribe to their use of the criteria exactly as
written. If the R.D.C. are used in a "mere checklist fashion" a
distinctly heterogeneous group of patients is identified. Alter-
natively an investigator can interpret the diagnostic criteria in
the light of his clinical judgment, and so narrow the group of
patients. One method of use raises questions about the useful-
ness of the R.D.C., the other, questions about their objectivity.
We agree with the need for caution, and would add that the
R.D.c. are similarly flawed for the endogenous subtype of
M.D.D.. For research purposes this is a more critical issue than
the validity of the general category M.D.D.: the Washington
University group acknowledge that their criteria3 (which
formed the basis for the R.D.C.) mix together endogenous and
neurotic depressions.’ That is essentially the point made by
Nelson et al.
The endogenous subtype of M.D.D., however, was proposed
for "those subjects who show a particular symptom picture
that many research studies indicate is associated with good re-
sponse to somatic therapy".2 These are also the patients for
whose depression a biological basis is commonly speculated.
Both we and Spitzer et al. use the diagnosis as elaborated by
Klein5 with his term "endogenomorphic depression".
We have compared the R.D.C. for endogenous M.D.D. with
our own clinical diagnoses in 48 consecutive outpatients pre-
senting to our affective-disorders clinic with a complaint of
depressed mood. All patients were seen by a psychiatrist in an
open clinical interview lasting an hour or more and by a clini-
cal social worker who administered the schedule for affective
disorders and schizophrenia.6 When possible, a family member
or some other significant person was seen in an adjunctive in-
terview. Initial clinical and R.D.C. diagnoses were made on the
basis of this information. The clinical diagnoses were reviewed
and revised on the basis of follow-up information gathered six
months to two years later. Follow-up diagnoses were based on
response to treatment, other aspects of the clinical course, and
information from the patients’ current therapist if we were no
longer seeing the patient. Patients were classified as having
endogenous depression or some other diagnosis both on clinical
criteria and on R.D.C. criteria. This led to the four-fold table
shown below. The R.D.C. led to both false-positive and false-
negative errors, with 30% of patients classified incorrectly.
Cohen’s kappa’ was 0.41, indicating poor agreement between
the clinical and R.D.c. diagnoses.8 Of the six patients incor-
rectly classed as not endogenously depressed by the R.D.C.
(false negatives), 3 were bipolar, with unequivocal episodes of
mania or hypomania meeting R.D.C. criteria. The 8 false-posit-
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RESULTS OF A STUDY OF 48 PATIENTS, COMPARING R.D.C.
DIAGNOSES AT INTAKE WITH CLINICAL DIAGNOSIS AFTER
TREATMENT AND FOLLOW-UP
ives were patients with atypical dysphoric presentations, whose
symptom profiles were widely divergent from the "coherent
syndrome" ordinarily recognised as endogenous depression.
We will not discuss in detail here the reasons why we think
the R.D.C. are inadequate per se for the diagnosis of endo-
genous depression. The important points are that a consider-
able refinement of the R.D.c. is needed, and that the R.D.C. do
not perform as supposed in identifying homogeneous groups of
patients for research. In fact, no "mere checklist" of clinical
features can be expected to select a completely homogeneous
group of patients. A diagnosis, even though generated by
"research" criteria, is nothing more than a statement of proba-
bility, which needs to be viewed in the light of clinical judg-
ment and commonsense.
Mental Health Research Institute,
University of Michigan,





WHO SHOULD MEASURE THE BLOOD-PRESSURE?
SIR,&mdash;I read your editorial (Jan. 20, p. 137) with great in-
terest.
It is a relief to see that the concept of home blood-pressure
measurement, promoted for so long by enthusiasts,1-4 has at
last obtained a measure of popular acceptance. Published work
from my department5 has clearly shown that patients can learn
to take their own blood-pressures without neurotic obsessions
developing, and often find it helpful in the management and
understanding of their condition. However, there is need for a
certain caution when it comes to chemist’s shop sphygmoman-
ometers. These semiautomatic instruments are often very inac-
curate6-9 and do not always over-read, as your editorial sug-
gests. The instrument reported in the National Press has been
evaluated in my department and found to be very unpredic-
table in this respect.
Home blood-pressures seldom tally closely with clinic
recordings.’’ On the contrary, clinical readings tend to be much
higher, particularly with respect to systolic pressure, and it
remains to be determined which type of measurement has the
greater prognostic significance in large-scale studies.
Northwick Park Hospital
and Clinical Research Centre,
Harrow, Middlesex HA1 3UJ E. B. RAFTERY
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